MOLECULAR BRAILLE Trademark
Trademark Overview
On Friday, December 18, 1998, a trademark application was filed for MOLECULAR BRAILLE with the United States Patent and Trademark Office. The USPTO has given the MOLECULAR BRAILLE trademark a serial number of 75608795. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 5, 2021. This trademark is owned by Novalon Pharmaceutical Corporation. The MOLECULAR BRAILLE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
DRUG DISCOVERY SERVICES, NAMELY SCREENING NUCLEAR RECEPTORS BY USING SURROGATE LIGANDS TO PROFILE SELECTIVE RECEPTOR MODULATORS IN VITRO AND CLASSIFYING DRUG LEADS INTO GROUPS OF TISSUE SELECTIVE AGONISTS AND ANTAGONISTS
General Information
Serial Number | 75608795 |
Word Mark | MOLECULAR BRAILLE |
Filing Date | Friday, December 18, 1998 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, November 5, 2021 |
Registration Number | 2392768 |
Registration Date | Tuesday, October 10, 2000 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 18, 2000 |
Trademark Statements
Goods and Services | DRUG DISCOVERY SERVICES, NAMELY SCREENING NUCLEAR RECEPTORS BY USING SURROGATE LIGANDS TO PROFILE SELECTIVE RECEPTOR MODULATORS IN VITRO AND CLASSIFYING DRUG LEADS INTO GROUPS OF TISSUE SELECTIVE AGONISTS AND ANTAGONISTS |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, November 5, 2021 |
Primary Code | 042 |
First Use Anywhere Date | Monday, May 25, 1998 |
First Use In Commerce Date | Monday, May 25, 1998 |
Trademark Owner History
Party Name | KARO BIO AB |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 03 - Corporation |
Address | HUDDINGE 14157 SE |
Party Name | Novalon Pharmaceutical Corporation |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Durham, NC 27703 |
Party Name | Novalon Pharmaceutical Corporation |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Durham, NC 27703 |
Party Name | Novalon Pharmaceutical Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Durham, NC 27703 |
Trademark Events
Event Date | Event Description |
Friday, November 5, 2021 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
Thursday, October 10, 2019 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Saturday, April 9, 2011 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
Saturday, April 9, 2011 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Friday, April 8, 2011 | TEAS SECTION 8 & 9 RECEIVED |
Friday, November 10, 2006 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Wednesday, November 1, 2006 | ASSIGNED TO PARALEGAL |
Tuesday, September 5, 2006 | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
Tuesday, September 5, 2006 | PAPER RECEIVED |
Friday, February 3, 2006 | CASE FILE IN TICRS |
Tuesday, October 10, 2000 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, July 18, 2000 | PUBLISHED FOR OPPOSITION |
Friday, June 16, 2000 | NOTICE OF PUBLICATION |
Wednesday, April 12, 2000 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, December 17, 1999 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, July 1, 1999 | NON-FINAL ACTION MAILED |
Wednesday, June 23, 1999 | ASSIGNED TO EXAMINER |